Ardena Expands into North America with Acquisition of Catalent’s Drug Manufacturing Facility in New Jersey

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) wit...

February 05, 2025 | Wednesday | News
Lonza Delivers CHF 6.6 Billion in 2024 Sales as CEO Wolfgang Wienand Drives One Lonza Strategy

In 2024, Lonza delivered sales of CHF 6.6 billion in line with prior year (-0.2% CER1) CORE EBITDA of CHF 1.9 billion at a margin of 29.0% The CDMO...

January 31, 2025 | Friday | Company results
Upperton Pharma Solutions Expands with New Sterile Manufacturing Facility in Nottingham

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing...

January 28, 2025 | Tuesday | News
Catalent and Galapagos Partner to Advance Decentralized Manufacturing of CAR-T Therapy for Aggressive Non-Hodgkin Lymphoma

Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic collaboration wi...

January 22, 2025 | Wednesday | News
ReciBioPharm Secures Gates Foundation Grant to Advance RNA Manufacturing Technologies for Global Health

3-year grant received from the Bill & Melinda Gates Foundation to enhance RNA production technologies Grant enables global implementation of the ...

January 21, 2025 | Tuesday | News
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching Expanded Global CDMO Operations

Tanvex BioPharma, Inc.  (“Tanvex”), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars product...

January 20, 2025 | Monday | News
Bio-Rad Launches Nuvia wPrime 2A Media for Scalable Biomolecule Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of ...

January 15, 2025 | Wednesday | News
BeiGene Exercises Option for DB1312/BG-C9074, Securing Global Rights to DualityBio's B7H4 Antibody-Drug Conjugate

Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its exclusive option for the B7H4 antibody-drug conjugate (ADC) DB1312/BG-C907...

December 31, 2024 | Tuesday | News
Catalent and Novo Holdings Clear Regulatory Hurdles, Transaction Close Imminent

Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Nov...

December 16, 2024 | Monday | News
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025

  In a compelling conversation with BioPharma BoardRoom, Venkata Indurthi, Chief Scientific Officer at Aldevron, shares insights into the inn...

December 12, 2024 | Thursday | Interaction
Amarna Therapeutics Forms Strategic Partnership with NorthX Biologics to Advance Gene Therapy Development

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company specializing in transformative gene therap...

December 04, 2024 | Wednesday | News
Polyrizon Signs Manufacturing Agreement with Eurofins CDMO for PL-14 Allergy Blocker Clinical Trial

Polyrizon Ltd. (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, anno...

December 03, 2024 | Tuesday | News
Adragos Pharma Acquires Baccinex, Strengthening Leadership in Aseptic Fill-Finish Across Europe, Japan, and Global Markets

Adragos Pharma, a global Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, has announced the acquisition of Baccinex, a...

November 27, 2024 | Wednesday | News
Hovione Expands Global Footprint with Major Investments in U.S. and Europe

    Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, just completed significant expansions in...

November 27, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close